TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Pain and Function as Measured by the American Society of Shoulder and Elbow Surgeons Questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absence of Radiographic Evidence of Failure or Pending Failure Based on Radiographic Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The Number of Device Related Serious Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: USG abnormality persistence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: separation of activity between lesion and non-lesional parenchyma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of Airflow Limitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Total number of patient responses to treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With Treated Biopsy-proven Acute Rejection (tBPAR) of Grade 1A or Higher, Graft Loss or Death
Endpoint domain: Mortality/survival
Primary endpoint: Geometric Mean Titers for Serum Anti-Human Papillomavirus (HPV) Types 6, 11, 16, and 18
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With Seropositivity to HPV Types 6, 11, 16, and 18
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Subjects Reaching Stabilization or Improvement in Clinical Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preparedness for Caregiving Measure
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Alzheimer's disease Knowledge Scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: healing of digital ulcer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Baseline-adjusted half-time hemoglobin re-oxygenation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Biomarker
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of orally administered DMARD or biologic treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total number of women who failed management with diet alone
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in subjective anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Internal services utilization
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Discrimination of studied groups
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Forensic cases admitted to Emergency department
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraoperatory vaginal bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Airway temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Airway humidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in crying time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Number of Patients With Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Patient Effectiveness Response Rating and Effective Rate of Humira With Disease Activity Score (DAS) 28 at Week 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Effectiveness Response Rating and Effective Rate of Humira With DAS 28 at Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Effectiveness Response Rating and Effective Rate of Humira With DAS 28 at Week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in bone volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Concentration of Antibiotics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Renal Oxygenation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Renal Perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Mitochondrial Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain following dilator placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IUD Expulsion Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Adverse events and serious adverse events occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Knowledge about risk factors for cardiovascular diseases
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Nonverbal Developmental Quotient (NVDQ)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Peak Oxygen Uptake (VO2peak)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body Mass Index (kg/m²)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Waist circumference (cm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Screen for Cognitive Impairment in Psychiatry (SCIP)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Frontal Assessment Battery (FAB)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Safety defined by adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Feasibility defined by ability to produce and administer CAR T cell product
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Serum low density lipoprotein (LDL)-cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Area under the curve from the time of dosing extrapolated to infinity (AUC(0-inf))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pupil diameter after hydrodissection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of postoperative sensory and motor block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sagittal condyle concentricity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sagittal disc position
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Linear glenoid fossa displacement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Superior joint space
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: eminence angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glenoid fossa angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnosis of gestational diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Anti-tumor efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Recruitment of families
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Retention of enrolled families
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Family participation rates
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Percentage of Participants Who Experienced a Dose Limiting Toxicity (DLT) During Cycle 1
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Who Experienced At Least One Adverse Event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Who Discontinued Study Intervention Due to an Adverse Event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Vascular endothelial growth factor level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change from baseline in mean time-matched QTcI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Area Under the Plasma Concentration of BCD-085-time Curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lumbar spine Bone Mineral Density (BMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Distant metastatic free survival
Endpoint domain: Mortality/survival
Primary endpoint: Number of subjects requiring COPD maintenance treatment and rescue medication
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of subjects with moderate and severe exacerbations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of subjects with COPD-related hospitalizations
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Aesthetic outcomes of breast ptosis surgery
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence of ocular adverse events in the study eye
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of serious adverse events in the study eye
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of ocular adverse events in the fellow eye
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of serious adverse events in the fellow eye
Endpoint domain: Adverse events/effects
Primary endpoint: Weekly Mean Number of Standard Drinks Consumed Per Day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in Mean Words for the Phonetic Portion of the Controlled Word Association Test (COWAT)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of Participants With Less Than 100 Hepatitis C Virus RNA Copies/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: times of pneumonia
Endpoint domain: Mortality/survival
Primary endpoint: Number of Participants With Symptom Success at 10 Weeks
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Participants With Symptom Success at 12 Months
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Medication Variability Observed in Immunosuppressant Labs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: duration of active phase and transition phase of labor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood Insulin AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Hunger iAUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Gamma Delta T Cell Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Loss of NAC sensory
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: intraoperative parathormone values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Plasma AUC After Dosing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma Cmax After Dosing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With Eradication of S. Aureus Nasal Carriage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: bioavailability (BA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brain connectivity changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Neurocognitive changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sealant retention scoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of COVID-19
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Burden level of caregiver management
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: First Appropriate ICD Shock
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Surgical success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinician Administered PTSD Scale for DSM-5 (CAPS-5)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hospital Administrative Data Showing 2 Mental Health Visits Completed
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Change from baseline on hemiplegic upper extremity sonography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wound Closure Rate of Diabetic Foot Ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: OUTCOME MESURE
Endpoint domain: null
Endpoint subdomain: null
Primary endpoint: Utility measured by EQ5D 5L
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Changes in Workforce Productivity and Activity Impairment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Changes in Physical Function and Limitations Due to Physical Health
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Clinical Remission of Depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Suicidal Ideation
Endpoint domain: Adverse events/effects
Primary endpoint: Safety of anesthetist administered sedation
Endpoint domain: Adverse events/effects
Primary endpoint: clinical response (cure or failure)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volume of Distribution of Radiolabeled GSK2256098
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Standardized Uptake Values (SUV) of Radiolabeled GSK2256098
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seeking of further medical attention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Area under the concentration-time curve from time zero to the time of the last quantifiable concentration (AUC 0-T)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration-time curve from time zero extrapolated to infinite time (AUC INF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent correct responses per day on phrase completion task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of sessions required to achieve mastery
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Retention of the reading material
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of Participants Who Did Not Use Chew/Dip in the Past 7 Days
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Motivation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Moderate to Vigorous Physical Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Steps Per Day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average Nutrient Intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of barriers in cervical cancer screening
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinical condition of acute severe pancreatitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Presence of pain or musculoskeletal (MSK) disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Severity of pain or MSK disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change from baseline scores on the MADRS
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Wagner stage increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Gremlin-1 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prognostic marker for predicting amputation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants with Selected FGFR Gene Aberrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Combined Symptom and Medication Score (CSMS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in Forced expiratory volume FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of Subjects With Dose-limiting Toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Subjects Experiencing Serious Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of adverse events of special interest (AESIs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change of cholesterol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Safety of autologous bone marrow-derived Mesenchymal Stem Cells
Endpoint domain: Adverse events/effects
Primary endpoint: Modified observer's assessment of alertness/sedation (MOAA/S)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Overall Pain Score Using the Visual Analog Scale (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Pain Severity Using Brief Pain Inventory (BPI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Pain Interference Using Brief Pain Inventory (BPI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dosage Adherence
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Regimen Adherence
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Time Adherence
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Peripheral visual field
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total time spent in target glucose level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Treatment emergent adverse and serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Glycated hemoglobin (HbA1C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Dynamic Component of Spasticity (Spasticity Angle)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: ICU admission rate
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Recurrent HSR
Endpoint domain: Adverse events/effects
Primary endpoint: International Consultation on Incontinence Questionnaire Short form (ICIQ_SF)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from baseline to postoperation in cognitive function
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from baseline to postoperation in recent memory
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from baseline to postoperation in attention
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from baseline to postoperation in pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline to postoperation in depression scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Whole body composition (lean body mass, total, and regional fat mass)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiorespiratory fitness/maximal oxygen consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Adherence in pregnant women
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of participants affected by adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Presence of molecular markers fulfilling eligibility criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of specific single-gene markers over-expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Predictive value of specific single-gene markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Corrected QT Interval (QTcN)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Normalization of urinary calcium levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: successful hemodynamic support
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Major Device-Related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: duration of infections
Endpoint domain: Adverse events/effects
Primary endpoint: days of fever
Endpoint domain: Adverse events/effects
Primary endpoint: Average Change in Urine Tumor Necrosis Factor (TNF)-Alpha From Baseline to Post-treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Average Change in Urine Interleukin (IL)-6 From Baseline to Post-treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes